文献速递儿科与产科急症

美国妊娠期体重增长与婴儿发病率及死亡率的相关性

Association of Gestational Weight Gain With Infant Morbidity and Mortality in the United States.
PubMed 文献 · JAMA Netw Open · 2021-12-01
一句话结论这项回顾性队列研究提示,按BMI分层的最佳妊娠期体重增长范围下限高于现行推荐,妊娠期体重增长不足与婴儿不良结局风险增加相关,作者认为不应将维持体重或减重作为常规指导。

该回顾性队列研究利用2011至2015年美国全国出生与婴儿死亡链接数据,纳入15 759 945对母婴,按母亲BMI分类分析妊娠期体重增长(以2.0 kg分组)与婴儿发病率及死亡率的关系,并确定与两种结局风险降低相关的最佳体重增长范围。结果显示,足月体重增长的最佳范围随BMI升高而降低:低体重及正常体重为12.0至不足24.0 kg,超重为10.0至不足20.0 kg,1级肥胖为8.0至不足16.0 kg,2级肥胖为6.0至不足16.0 kg,3级肥胖为6.0至不足10.0 kg。作者指出,即使对肥胖女性,体重增长不足也与婴儿不良结局风险增加相关,提示不应将维持体重或减重作为常规指导。

要点

  • 在15 759 945对母婴中,8.8%的新生儿发生显著发病率,正常体重组最低为8.0%,3级肥胖组最高为12.4%。
  • 0.34%的婴儿在出生后1年内死亡,正常体重组最低为0.28%,3级肥胖组最高为0.58%。
  • 最佳妊娠期体重增长范围:低体重及正常体重12.0至不足24.0 kg,超重10.0至不足20.0 kg,1级肥胖8.0至不足16.0 kg,2级肥胖6.0至不足16.0 kg,3级肥胖6.0至不足10.0 kg。
  • 最佳范围下限高于现行推荐:超重10.0 vs 7.0 kg,1级肥胖8.0 vs 5.0 kg,2级肥胖6.0 vs 5.0 kg,3级肥胖6.0 vs 5.0 kg。
  • 作者认为,体重维持或减重不应作为常规指导。

适用人群与场景

  • 2011至2015年美国全国出生与婴儿死亡链接数据中的母亲-婴儿对,共15 759 945对。
  • 按母亲孕前BMI分类:低体重、正常体重、超重、1级肥胖、2级肥胖、3级肥胖。

诊断标准与关键阈值

  • 新生儿显著发病率定义:出现以下任一情况:辅助通气、新生儿重症监护病房入院、表面活性物质治疗、抗生素治疗或惊厥。
  • 婴儿死亡率定义:出生后1岁以内死亡,按出生后<1小时、1-23小时、1-6天、7-27天、28-365天分层。

研究设计与关键结果

  • 研究设计:回顾性队列研究,使用美国全国出生与婴儿死亡链接数据,纳入15 759 945对母婴。
  • 母亲平均(SD)年龄28.1(5.9)岁,孕期平均(SD)体重增长14.1(7.3)kg,且随BMI分类升高而降低:低体重15.7(6.4)kg、正常体重15.4(6.2)kg、超重14.2(7.4)kg、1级肥胖12.2(8.0)kg、2级肥胖10.3(8.4)kg、3级肥胖8.2(9.2)kg,P < .001。
  • 8.8%的新生儿发生显著发病率,正常体重组最低8.0%,3级肥胖组最高12.4%。
  • 0.34%的婴儿在出生后1年内死亡,正常体重组最低0.28%,3级肥胖组最高0.58%。
  • 最佳妊娠期体重增长范围:低体重及正常体重12.0至不足24.0 kg,超重10.0至不足20.0 kg,1级肥胖8.0至不足16.0 kg,2级肥胖6.0至不足16.0 kg,3级肥胖6.0至不足10.0 kg。
  • 最佳范围下限高于现行推荐:超重10.0 vs 7.0 kg,1级肥胖8.0 vs 5.0 kg,2级肥胖6.0 vs 5.0 kg,3级肥胖6.0 vs 5.0 kg。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,体重维持或减重不应作为常规指导;即使对肥胖女性,妊娠期体重增长不足也与婴儿不良结局风险增加相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The associations of gestational weight gain (GWG) with infant morbidity and mortality are unclear, and the existing recommendations for GWG have not been stratified by the severity of obesity.

OBJECTIVES: To identify optimal GWG ranges associated with reduced risks of infant morbidity and mortality across maternal body mass index (BMI) categories.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used US nationwide, linked birth and infant death data between 2011 and 2015 to assess the associations of GWG in 2.0-kg groups with infant morbidity and mortality and identified optimal GWG ranges associated with reduced risks of both outcomes, using multivariable logistic regression models. Statistical analysis was performed from February 11 to October 14, 2021.

EXPOSURE: Gestational weight gain equivalent to 40 weeks.

MAIN OUTCOMES AND MEASURES: The 2 main outcomes were (1) significant morbidity of the newborn infant, defined as any presence of assisted ventilation, admission to the neonatal intensive care unit, surfactant therapy, antibiotic therapy, or seizures; and (2) infant mortality younger than 1 year of age (<1 hour, 1-23 hours, 1-6 days, 7-27 days, or 28-365 days after birth).

RESULTS: In this study of 15 759 945 mother-infant dyads, the mean (SD) age of the women was 28.1 (5.9) years. Women gained a mean (SD) of 14.1 (7.3) kg during pregnancy, and the mean (SD) GWG decreased with BMI categories (underweight, 15.7 [6.4] kg; normal weight, 15.4 [6.2] kg; overweight, 14.2 [7.4] kg; obesity class 1, 12.2 [8.0] kg; obesity class 2, 10.3 [8.4] kg; obesity class 3, 8.2 [9.2] kg; P < .001). A total of 8.8% of the newborns experienced significant morbidity, with the lowest prevalence among infants delivered by women in the normal weight BMI class (8.0%) and the highest among infants delivered by women with class 3 obesity (12.4%); 0.34% of infants died within 1 year of birth, with the lowest prevalence among infants delivered by women in the normal weight BMI class (0.28%) and the highest among infants delivered by women with class 3 obesity (0.58%). Optimal GWG ranges were 12.0 to less than 24.0 kg for underweight and normal weight women, 10.0 to less than 20.0 kg for overweight women, 8.0 to less than 16.0 kg for women with class 1 obesity, 6.0 to less than 16.0 kg for class 2 obesity, and 6.0 to less than 10.0 kg for class 3 obesity. The lower bounds of the optimal GWG ranges appeared to be higher than the existing recommendations for overweight women (10.0 vs 7.0 kg) and for those with class 1 (8.0 vs 5.0 kg), class 2 (6.0 vs 5.0 kg), and class 3 (6.0 vs 5.0 kg) obesity.

CONCLUSIONS AND RELEVANCE: This study analyzed the associations of GWG with infant morbidity and mortality across BMI categories and found that inadequate GWG was associated with increased risks of adverse infant outcomes even for women with obesity. The results suggested that weight maintenance or weight loss should not be used as routine guidelines.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Wang L, Zhang X, Chen T, et al. Association of Gestational Weight Gain With Infant Morbidity and Mortality in the United States. JAMA Netw Open. 2021. PMID: 34967878. doi:10.1001/jamanetworkopen.2021.41498

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。